Contents

Current Cancer Drug Targets, Volume 8 - Number 1

Editorial [Hot Topic: Akt Pathway in Oncogenesis and as a Target for Anti-Cancer Therapy (Guest Editor: Jin Q. Cheng) ]

, 8(1): 1

Jin Q. Cheng


DOI: 10.2174/156800908783497104




Advances of AKT Pathway in Human Oncogenesis and as a Target for Anti-Cancer Drug Discovery

, 8(1): 2 - 6

Lu-Hai Wang, George Z. Cheng, Sungman Park, Shaokun Shu, Lili He, William Kong, Weizhou Zhang, Zengqiang Yuan and Jin Q. Cheng


DOI: 10.2174/156800908783497159




The PI3K/Akt Pathway: Recent Progress in the Development of ATP-Competitive and Allosteric Akt Kinase Inhibitors

, 8(1): 7 - 18

Craig W. Lindsley, Stanley F. Barnett, Mark E. Layton and Mark T. Bilodeau


DOI: 10.2174/156800908783497096




AKT Signaling in Regulating Angiogenesis

, 8(1): 19 - 26

Bing-Hua Jiang and Ling-Zhi Liu


DOI: 10.2174/156800908783497122




Deregulation of the Akt Pathway in Human Cancer

, 8(1): 27 - 36

Eriko Tokunaga, Eiji Oki, Akinori Egashira, Noriaki Sadanaga, Masaru Morita, Yoshihiro Kakeji and Yoshihiko Maehara


DOI: 10.2174/156800908783497140




Cellular FLICE-Like Inhibitory Protein (C-FLIP): A Novel Target for Cancer Therapy

, 8(1): 37 - 46

Ahmad R. Safa, Travis W. Day and Ching-Huang Wu


DOI: 10.2174/156800908783497087




Targeting P-glycoprotein for Effective Oral Anti-Cancer Chemotherapeutics

, 8(1): 47 - 52

M. Bebawy and D. M. Sze


DOI: 10.2174/156800908783497168




Inhibitors of Cyclin Dependent Kinases: Useful Targets for Cancer Treatment

, 8(1): 53 - 75

P. Sapra Sharma, R. Sharma and R. Tyagi


DOI: 10.2174/156800908783497131




Small Molecule Tyrosine Kinase Inhibitors: Potential Role in Pediatric Malignant Solid Tumors

, 8(1): 76 - 85

Jochen Rossler, Birgit Geoerger, Melissa Taylor and Gilles Vassal


DOI: 10.2174/156800908783497113




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science